PACS Group Inc header image

PACS Group Inc

PACS

Equity

ISIN US69380Q1076 / Valor 133777092

New York Stock Exchange, Inc (2024-11-21)
USD 16.55-4.06%

PACS Group Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

PACS Group, Inc. (PACS) is a holding company that has significantly expanded its footprint in the healthcare sector, specifically focusing on the post-acute care industry since its inception in 2013. Starting with just two skilled nursing facilities, PACS has grown into a substantial network, now encompassing over 200 facilities across nine states. The company's growth strategy involves investing in post-acute care facilities, healthcare professionals, and ancillary services to provide comprehensive care. PACS emphasizes a model that combines the benefits of a national support network with the autonomy of local decision-making in its operations. As of now, PACS and its affiliates manage 218 facilities, employing over 32,000 staff members, and cater to the daily needs of more than 20,000 patients and residents. This expansion reflects PACS's commitment to delivering mission-driven care and addressing the growing demand for post-acute healthcare services in the United States.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (12.06.2024):

Revenue Growth

PACS Group Inc. reported a significant increase in revenue for the first quarter of 2024, with consolidated GAAP revenue reaching $934.7 million. This represents a 31.9% increase over the same quarter in the previous year, driven by both an increase in occupancy rates and the addition of new facilities.

Net Income and Earnings Per Share

For the first quarter of 2024, PACS Group Inc. achieved a net income of $49.1 million, which is a 30.7% increase compared to the first quarter of the previous year. The GAAP earnings per share also rose by 31.0% to $0.38, reflecting the company's strong financial performance and operational efficiency.

Adjusted EBITDA and EBITDAR

The company's EBITDA for the first quarter of 2024 stood at $96.3 million, showing a 47.0% increase from the previous year. Adjusted EBITDA was reported at $88.5 million, up by 34.0%, and Adjusted EBITDAR reached $152.5 million, highlighting effective cost management and operational improvements.

Operational Highlights

During the first quarter of 2024, PACS Group Inc. maintained a strong operational performance with an occupancy rate of 91.1%. The company also expanded its portfolio by adding 10 new operating facilities, which included 1,334 skilled nursing and 174 assisted living beds, enhancing its service capacity and market reach.

Future Outlook

Looking ahead to the full year of 2024, PACS Group Inc. has provided a revenue guidance of between $3.65 billion to $3.75 billion and an Adjusted EBITDA forecast of $351 million to $361 million. This outlook is based on the company's current operations and market conditions as of May 13, 2024, reflecting confidence in continued growth and operational success.

Summarized from source with an LLMView Source

Key figures

%1Y
%3Y
%5Y

Performance

41.5%1Y
41.5%3Y
41.5%5Y

Volatility

Market cap

3180 M

Market cap (USD)

Daily traded volume (Shares)

347,810

Daily traded volume (Shares)

1 day high/low

17.39 / 16.53

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Cassava Sciences Inc
Cassava Sciences Inc Cassava Sciences Inc Valor: 46983284
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
23.53%USD 32.18
Ligand Pharmaceuticals Inc
Ligand Pharmaceuticals Inc Ligand Pharmaceuticals Inc Valor: 12015449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.47%USD 116.55
RadNet Inc
RadNet Inc RadNet Inc Valor: 2812237
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.05%USD 81.30
CryoPort Inc
CryoPort Inc CryoPort Inc Valor: 28284615
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.76%USD 6.52
LeMaitre Vascular inc
LeMaitre Vascular inc LeMaitre Vascular inc Valor: 2755054
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.35%USD 105.87
Opko Health Inc
Opko Health Inc Opko Health Inc Valor: 3094438
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.27%USD 1.56
Healthcare Services Group Inc
Healthcare Services Group Inc Healthcare Services Group Inc Valor: 938239
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.14%USD 11.52
Astellas Seiyaku KK
Astellas Seiyaku KK Astellas Seiyaku KK Valor: 764030
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.03%JPY 1,572.00
Terumo KK
Terumo KK Terumo KK Valor: 763585
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.82%JPY 3,038.00
KK Shiseido
KK Shiseido KK Shiseido Valor: 763285
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.27%JPY 2,748.00